Early research (Phase 1)Study completedNCT00651027
What this trial is testing
Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554
Who this might be right for
HEPATITIS C (HCV)
Pfizer 24